entrectinib January 19, 2018 entrectinib Trade Name Orphan Indication NTRK fusion-positive solid tumors USA Market Approval USA USA Designation Date 2017-07-05 00:00:00 Sponsor Ignyta, Inc.;4545 Towne Centre Court;San Diego, California, 92121
